abrdn Life Sciences Investors (HQL) vs Invesco Value Municipal Income (IIM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
abrdn Life Sciences Investors (HQL) has outperformed Invesco Value Municipal Income (IIM) over the past year, losing 8.5% versus a loss of 16.2%. Over five years, HQL leads with a -22.8% price change compared with -37.4% for IIM. On valuation, abrdn Life Sciences Investors trades at a lower trailing P/E (2.3x vs 12.8x for Invesco Value Municipal Income).
abrdn Life Sciences Investors offers the higher dividend yield (12.42% vs 8.89%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HQL | IIM |
|---|---|---|
| Share price | $15.38 | $10.38 |
| Market cap | — | $489.27M |
| 1-day change | -3.81% | +0.48% |
| YTD return | -8.34% | -15.75% |
| 1-year return | -8.51% | -16.16% |
| 5-year return | -22.83% | -37.39% |
| P/E ratio (TTM) | 2.32 | 12.81 |
| EPS (TTM) | $6.64 | $0.81 |
| Dividend yield | 12.42% | 8.89% |
| Annual dividend | $1.91 | $0.923 |
| 52-week high | $22.67 | $13.17 |
| 52-week low | $15.35 | $10.27 |
| Distance from 52-week high | -32.16% | -21.18% |
| Analyst consensus | — | none |
| Average volume | 129.21K | 200.65K |
| Shares outstanding | — | 47.14M |
| Sector | Finance | Finance |
| Industry | Investment Managers | Investment Managers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Invesco Value Municipal Income trades at a higher earnings multiple (12.8x vs 2.3x trailing P/E).
- abrdn Life Sciences Investors offers a meaningfully higher dividend yield (12.42% vs 8.89%).
About abrdn Life Sciences Investors
HQL stock →Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.
Finance · Investment Managers
About Invesco Value Municipal Income
IIM stock →Invesco Value Municipal Income Trust is a closed-ended fixed income mutual fund launched by Invesco Ltd. The fund is co-managed by Invesco Advisers, Inc., INVESCO Asset Management (Japan) Limited, INVESCO Asset Management Deutschland GmbH, INVESCO Asset Management Limited, Invesco Canada Ltd., Invesco Hong Kong Limited, and INVESCO Senior Secured Management, Inc.
Finance · Investment Managers
HQL vs IIM FAQ
Which stock has performed better over the past year, HQL or IIM?
HQL returned -8.51% over the past 12 months, compared with -16.16% for IIM (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, HQL or IIM?
HQL has the lower trailing P/E at 2.3, versus 12.8 for IIM. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, abrdn Life Sciences Investors or Invesco Value Municipal Income?
abrdn Life Sciences Investors has the higher yield at 12.42%, compared with 8.89% for Invesco Value Municipal Income.
Are abrdn Life Sciences Investors and Invesco Value Municipal Income in the same industry?
Yes. Both are classified in the Investment Managers industry within the Finance sector.